Diet-Induced Obesity Disrupts Histamine-Dependent Oleoylethanolamide Signaling in the Mouse Liver

Pharmacology. 2022;107(7-8):423-432. doi: 10.1159/000524753. Epub 2022 Jun 10.

Abstract

Introduction: Previous work suggests the existence of a paracrine signaling mechanism in which histamine released from visceral mast cells into the portal circulation contributes to fasting-induced ketogenesis by stimulating biosynthesis of the endogenous high-affinity PPAR-α agonist oleoylethanolamide (OEA).

Methods: Male C57Bl/6J mice were rendered obese by exposure to a high-fat diet (HFD; 60% fat). We measured histamine, OEA, and other fatty-acid ethanolamides by liquid-chromatography/mass spectrometry, gene transcription by RT-PCR, protein expression by ELISA, neutral lipid accumulation in the liver using Red Oil O and BODIPY staining, and collagen levels using picrosirius red staining.

Results: Long-term exposure to HFD suppressed both fasting-induced histamine release into portal blood and histamine-dependent OEA production in the liver. Additionally, subchronic OEA administration reduced lipid accumulation, inflammatory responses, and fibrosis in the liver of HFD-exposed mice.

Discussion: The results suggest that disruption of histamine-dependent OEA signaling in the liver might contribute to pathology in obesity-associated liver steatosis.

Keywords: Histamine; Liver steatosis; Obesity; Oleoylethanolamide; Peroxisome proliferator-activated receptor-α.

MeSH terms

  • Animals
  • Diet, High-Fat / adverse effects
  • Endocannabinoids / metabolism
  • Histamine* / metabolism
  • Liver / metabolism
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Obesity / metabolism
  • Oleic Acids
  • PPAR alpha* / genetics

Substances

  • Endocannabinoids
  • Oleic Acids
  • PPAR alpha
  • oleoylethanolamide
  • Histamine